Sotalol-induced bradycardia reversed by glucagon

C. M.B. Fernandes, M. R. Daya

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Glucagon is considered the drug of choice for treating bradycardia and hypotension encountered during β-blocker poisoning. Its potential usefulness is reversing adverse effects encountered during therapeutic dosing with β-blocker has not been well characterized. We present a case of sotalol-induced bradycardia reversed by glucagon.

Original languageEnglish (US)
Pages (from-to)659-660+663
JournalCanadian Family Physician
Issue numberAPR.
StatePublished - 1995
Externally publishedYes

ASJC Scopus subject areas

  • Family Practice


Dive into the research topics of 'Sotalol-induced bradycardia reversed by glucagon'. Together they form a unique fingerprint.

Cite this